140 related articles for article (PubMed ID: 28409646)
1. Intravitreal bevacizumab alters type IV collagenases and exacerbates arrested alveologenesis in the neonatal rat lungs.
Valencia AM; Cai CL; Tan J; Duggan TJ; Valencia GB; Aranda JV; Beharry KD
Exp Lung Res; 2017 Apr; 43(3):120-133. PubMed ID: 28409646
[TBL] [Abstract][Full Text] [Related]
2. Acute and chronic effects of intravitreal bevacizumab on lung biomarkers of angiogenesis in the rat exposed to neonatal intermittent hypoxia.
Duggan TJ; Cai CL; Aranda JV; Beharry KD
Exp Lung Res; 2021 Apr; 47(3):121-135. PubMed ID: 33377400
[TBL] [Abstract][Full Text] [Related]
3. Ocular Adverse Effects of Intravitreal Bevacizumab Are Potentiated by Intermittent Hypoxia in a Rat Model of Oxygen-Induced Retinopathy.
Tan JJ; Cai CL; Shrier EM; McNally L; Lazzaro DR; Aranda JV; Beharry KD
J Ophthalmol; 2017; 2017():4353129. PubMed ID: 28770109
[TBL] [Abstract][Full Text] [Related]
4. Effects of a superoxide dismutase mimetic on biomarkers of lung angiogenesis and alveolarization during hyperoxia with intermittent hypoxia.
Chang M; Bany-Mohammed F; Kenney MC; Beharry KD
Am J Transl Res; 2013; 5(6):594-607. PubMed ID: 24093057
[TBL] [Abstract][Full Text] [Related]
5. [Study on effect of dexamethasone on the expression of matrix metalloproteinase and its tissue inhibitors in hyperoxia-induced lung injury].
Liu CJ; Xu F; Kuang FW; Dang R; Lu ZY; Wang XY
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2004 Oct; 16(10):618-21. PubMed ID: 15461845
[TBL] [Abstract][Full Text] [Related]
6. Increased lung matrix metalloproteinase-9 levels in extremely premature baboons with bronchopulmonary dysplasia.
Tambunting F; Beharry KD; Hartleroad J; Waltzman J; Stavitsky Y; Modanlou HD
Pediatr Pulmonol; 2005 Jan; 39(1):5-14. PubMed ID: 15521085
[TBL] [Abstract][Full Text] [Related]
7. Hyperoxia decreases matrix metalloproteinase-9 and increases tissue inhibitor of matrix metalloproteinase-1 protein in the newborn rat lung: association with arrested alveolarization.
Hosford GE; Fang X; Olson DM
Pediatr Res; 2004 Jul; 56(1):26-34. PubMed ID: 15128910
[TBL] [Abstract][Full Text] [Related]
8. Low levels of tissue inhibitors of metalloproteinases with a high matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio are present in tracheal aspirate fluids of infants who develop chronic lung disease.
Ekekezie II; Thibeault DW; Simon SD; Norberg M; Merrill JD; Ballard RA; Ballard PL; Truog WE
Pediatrics; 2004 Jun; 113(6):1709-14. PubMed ID: 15173495
[TBL] [Abstract][Full Text] [Related]
9. The effects of selective COX-2 inhibitor/celecoxib and omega-3 fatty acid on matrix metalloproteinases, TIMP-1, and laminin-5gamma2-chain immunolocalization in experimental periodontitis.
Vardar-Sengul S; Buduneli E; Turkoglu O; Buduneli N; Atilla G; Wahlgren J; Sorsa T; Baylas H
J Periodontol; 2008 Oct; 79(10):1934-41. PubMed ID: 18834249
[TBL] [Abstract][Full Text] [Related]
10. The distribution of matrix metalloproteinases and tissue inhibitors of metalloproteinases in the lungs of congenital diaphragmatic hernia patients and age-matched controls.
Masumoto K; de Rooij JD; Suita S; Rottier R; Tibboel D; de Krijger RR
Histopathology; 2006 Apr; 48(5):588-95. PubMed ID: 16623785
[TBL] [Abstract][Full Text] [Related]
11. Early postnatal dexamethasone influences matrix metalloproteinase-2 and -9, and their tissue inhibitors in the developing rat lung.
Valencia AM; Beharry KD; Ang JG; Devarajan K; Van Woerkom R; Abrantes M; Nishihara K; Chang E; Waltzman J; Modanlou HD
Pediatr Pulmonol; 2003 Jun; 35(6):456-62. PubMed ID: 12746943
[TBL] [Abstract][Full Text] [Related]
12. Intermittent hypoxia during recovery from neonatal hyperoxic lung injury causes long-term impairment of alveolar development: A new rat model of BPD.
Mankouski A; Kantores C; Wong MJ; Ivanovska J; Jain A; Benner EJ; Mason SN; Tanswell AK; Auten RL; Jankov RP
Am J Physiol Lung Cell Mol Physiol; 2017 Feb; 312(2):L208-L216. PubMed ID: 27913427
[TBL] [Abstract][Full Text] [Related]
13. Altered gene expression levels of matrix metalloproteinases and their inhibitors in periodontitis-affected gingival tissue.
Kubota T; Itagaki M; Hoshino C; Nagata M; Morozumi T; Kobayashi T; Takagi R; Yoshie H
J Periodontol; 2008 Jan; 79(1):166-73. PubMed ID: 18166107
[TBL] [Abstract][Full Text] [Related]
14. The effect of epidermal growth factor on matrix metalloproteinases and tissue inhibitors of metalloproteinase gene expression in cultured human gingival fibroblasts.
Cury PR; de Araújo VC; Canavez F; Furuse C; Leite KR; de Araújo NS
Arch Oral Biol; 2007 Jun; 52(6):585-90. PubMed ID: 17181997
[TBL] [Abstract][Full Text] [Related]
15. Relevance of tenascin-C and matrix metalloproteinases in vascular abnormalities in murine hypoplastic lungs.
Chinoy MR; Miller SA
Biol Neonate; 2006; 90(3):185-96. PubMed ID: 16699260
[TBL] [Abstract][Full Text] [Related]
16. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
17. Gene expressions and roles of matrix metalloproteinases-8 and tissue inhibitor of metalloproteinases-1 in hyperoxia-induced pulmonary fibrosis in neonatal rats.
Fu JH; Xue XD
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Feb; 9(1):1-5. PubMed ID: 17306066
[TBL] [Abstract][Full Text] [Related]
18. Localization of matrix metalloproteinases-1, -2, and -9 and tissue inhibitor of metalloproteinase-2 in interstitial lung diseases.
Fukuda Y; Ishizaki M; Kudoh S; Kitaichi M; Yamanaka N
Lab Invest; 1998 Jun; 78(6):687-98. PubMed ID: 9645759
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinases 2, 9, and 13, and tissue inhibitors of metalloproteinases 1 and 2 in experimental lung silicosis.
Pérez-Ramos J; de Lourdes Segura-Valdez M; Vanda B; Selman M; Pardo A
Am J Respir Crit Care Med; 1999 Oct; 160(4):1274-82. PubMed ID: 10508819
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical study of metalloproteinases and their tissue inhibitors in the lungs of patients with diffuse alveolar damage and idiopathic pulmonary fibrosis.
Hayashi T; Stetler-Stevenson WG; Fleming MV; Fishback N; Koss MN; Liotta LA; Ferrans VJ; Travis WD
Am J Pathol; 1996 Oct; 149(4):1241-56. PubMed ID: 8863673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
